Show results for
Refine by
Injection Separation Technology Articles & Analysis
8 news found
Long-Acting Controlled-Release Injection Technologies Another groundbreaking development by CD Formulation is its long-acting controlled-release injection technologies. ...
ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming the fill and finish and delivery of injectable vaccines and medicines, announced today that it had completed a $111 million private round of investment. This investment round values ApiJect at approximately $300 million. The new round was led by Royalty Pharma and ...
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce a non-brokered private placement financing (the “Offering”) of up to 8,333,333 units (each, a ...
Camurus (NASDAQ STO: CAMX) today announces that the company’s license partner Rhythm Pharmaceuticals has dosed the first patients in a Phase 3 trial evaluating weekly setmelanotide subcutaneous depot in patients six years of age and older with a rare genetic disease of obesity. “We are pleased with the progress of our collaboration with Rhythm and today’s announcement of the ...
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ product portfolio as well ...
InGeneron, Inc., a regenerative medicine and cell therapy company, announced today the enrollment of the first patients in a pivotal study evaluating InGeneron’s cell therapy as a way to treat partial thickness rotator cuff tears involving a partial tear in the supraspinatus tendon. The primary goal of the double-blinded, multi-center trial is to demonstrate the effectiveness of the ...
The SAS-ES MIST system is designed to combine the SAS-ES products with the right engineering setup. Chemical injection and the following separation of the waste into oil, water and solids can be achieved routinely if provided with the right setup and the right training for the team. This system allows for fast setup and implementation of the SAS-ES process. ES 20' MIST System is packaged ...
Solvay Specialty Polymers has unveiled an enhanced version of its Lavanta® High-Performance Polyester (HPP) for production of light-emitting diodes (LEDs) for televisions and backlight unit (BLU) applications. The second-generation product – Lavanta 5115 WH 224 – provides significantly improved processability while maintaining its high heat and light stability. “This ...